[EN] OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING [FR] COMPOSÉS FLUOROPHORES HYDROSOLUBLES À BASE D'OXAZINE POUR IMAGERIE NERVEUSE IN VIVO
[EN] WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING [FR] COLORANTS POUR NERFS SOLUBLES DANS L'EAU POUR IMAGERIE SPÉCIFIQUE DES NERFS IN VIVO
摘要:
Provided herein are libraries of nerve-specific fluorescent contrast agents of substituted 8-methyl-phenoxazine compounds of Formula (I) with excitation and emission profile comparable to US FDA approved methylene blue (MB) and indocyanine green (ICG), respectively, allowing for real-time intraoperative imaging using clinical-grade surgical systems. Also provided 700 nm lead candidates with substantially improved water-solubility, fully negating the need for formulation development with the added advantage of improved safety profiles for patient use in the clinic as well as decreased overall cost of clinical translation.
[EN] OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING<br/>[FR] COMPOSÉS FLUOROPHORES HYDROSOLUBLES À BASE D'OXAZINE POUR IMAGERIE NERVEUSE IN VIVO
申请人:UNIV OREGON HEALTH & SCIENCE
公开号:WO2021138116A1
公开(公告)日:2021-07-08
This invention provides novel oxazine-based, water soluble fluorophore compounds useful in in vivo nerve imaging, as well as compositions comprising them and methods for their use.
[EN] NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION<br/>[FR] FORMULATIONS DE FLUOROPHORE SPÉCIFIQUES AUX NERFS POUR UNE ADMINISTRATION DIRECTE ET SYSTÉMIQUE
申请人:UNIV OREGON HEALTH & SCIENCE
公开号:WO2021158820A1
公开(公告)日:2021-08-12
Nerve-specific fluorophore formulations of Formula (I) for direct or systemic administration are described. The formulations can be used in fluorescence-guided surgery (FGS) to aid in nerve preservation during surgical interventions.
[EN] WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING<br/>[FR] COLORANTS POUR NERFS SOLUBLES DANS L'EAU POUR IMAGERIE SPÉCIFIQUE DES NERFS IN VIVO
申请人:[en]OREGON HEALTH & SCIENCE UNIVERSITY
公开号:WO2023278874A1
公开(公告)日:2023-01-05
Provided herein are libraries of nerve-specific fluorescent contrast agents of substituted 8-methyl-phenoxazine compounds of Formula (I) with excitation and emission profile comparable to US FDA approved methylene blue (MB) and indocyanine green (ICG), respectively, allowing for real-time intraoperative imaging using clinical-grade surgical systems. Also provided 700 nm lead candidates with substantially improved water-solubility, fully negating the need for formulation development with the added advantage of improved safety profiles for patient use in the clinic as well as decreased overall cost of clinical translation.